Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases

Elisa Fermo, Cristina Vercellati, Anna Paola Marcello, Anna Zaninoni, Selin Aytac, Mualla Cetin, Ilaria Capolsini, Maddalena Casale, Sabrina Paci, Alberto Zanella, Wilma Barcellini, Paola Bianchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Glucose-6-phosphate isomerase (GPI, EC 5.3.1.9) is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate, the second reaction step of glycolysis. GPI deficiency, transmitted as an autosomal recessive trait, is considered the second most common erythro-enzymopathy of anaerobic glycolysis, after pyruvate kinase deficiency. Despite this, this defect may sometimes be misdiagnosed and only about 60 cases of GPI deficiency have been reported. GPI deficient patients are affected by chronic nonspherocytic hemolytic anemia of variable severity; in rare cases, intellectual disability or neuromuscular symptoms have also been reported. The gene locus encoding GPI is located on chromosome 19q13.1 and contains 18 exons. So far, about 40 causative mutations have been identified. We report the clinical, hematological and molecular characteristics of 12 GPI deficient cases (eight males, four females) from 11 families, with a median age at admission of 13 years (ranging from 1 to 51); eight of them were of Italian origin. Patients displayed moderate to severe anemia, that improves with aging. Splenectomy does not always result in the amelioration of anemia but may be considered in transfusion-dependent patients to reduce transfusion intervals. None of the patients described here displayed neurological impairment attributable to the enzyme defect. We identified 13 different mutations in the GPI gene, six of them have never been described before; the new mutations affect highly conserved residues and were not detected in 1000 Genomes and HGMD databases and were considered pathogenic by several mutation algorithms. This is the largest series of GPI deficient patients so far reported in a single study. The study confirms the great heterogeneity of the molecular defect and provides new insights on clinical and molecular aspects of this disease.

Original languageEnglish
Article number467
JournalFrontiers in Physiology
Volume10
Issue numberMAY
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Glucose-6-Phosphate Isomerase
Mutation
Glycolysis
Anemia
Glucose-6-Phosphate
Hemolytic Anemia
Splenectomy
Enzymes
Diagnostic Errors
Intellectual Disability
Genes
Exons
Chromosomes
Genome
Databases

Keywords

  • Chronic hemolytic anemias
  • Glucose-6-phosphate isomerase deficiency
  • Glycolysis
  • Red cell disorders
  • Red cell metabolism

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases. / Fermo, Elisa; Vercellati, Cristina; Marcello, Anna Paola; Zaninoni, Anna; Aytac, Selin; Cetin, Mualla; Capolsini, Ilaria; Casale, Maddalena; Paci, Sabrina; Zanella, Alberto; Barcellini, Wilma; Bianchi, Paola.

In: Frontiers in Physiology, Vol. 10, No. MAY, 467, 01.01.2019.

Research output: Contribution to journalArticle

@article{f3601deed00b422595ac56b050923be1,
title = "Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases",
abstract = "Glucose-6-phosphate isomerase (GPI, EC 5.3.1.9) is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate, the second reaction step of glycolysis. GPI deficiency, transmitted as an autosomal recessive trait, is considered the second most common erythro-enzymopathy of anaerobic glycolysis, after pyruvate kinase deficiency. Despite this, this defect may sometimes be misdiagnosed and only about 60 cases of GPI deficiency have been reported. GPI deficient patients are affected by chronic nonspherocytic hemolytic anemia of variable severity; in rare cases, intellectual disability or neuromuscular symptoms have also been reported. The gene locus encoding GPI is located on chromosome 19q13.1 and contains 18 exons. So far, about 40 causative mutations have been identified. We report the clinical, hematological and molecular characteristics of 12 GPI deficient cases (eight males, four females) from 11 families, with a median age at admission of 13 years (ranging from 1 to 51); eight of them were of Italian origin. Patients displayed moderate to severe anemia, that improves with aging. Splenectomy does not always result in the amelioration of anemia but may be considered in transfusion-dependent patients to reduce transfusion intervals. None of the patients described here displayed neurological impairment attributable to the enzyme defect. We identified 13 different mutations in the GPI gene, six of them have never been described before; the new mutations affect highly conserved residues and were not detected in 1000 Genomes and HGMD databases and were considered pathogenic by several mutation algorithms. This is the largest series of GPI deficient patients so far reported in a single study. The study confirms the great heterogeneity of the molecular defect and provides new insights on clinical and molecular aspects of this disease.",
keywords = "Chronic hemolytic anemias, Glucose-6-phosphate isomerase deficiency, Glycolysis, Red cell disorders, Red cell metabolism",
author = "Elisa Fermo and Cristina Vercellati and Marcello, {Anna Paola} and Anna Zaninoni and Selin Aytac and Mualla Cetin and Ilaria Capolsini and Maddalena Casale and Sabrina Paci and Alberto Zanella and Wilma Barcellini and Paola Bianchi",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fphys.2019.00467",
language = "English",
volume = "10",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",
number = "MAY",

}

TY - JOUR

T1 - Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases

AU - Fermo, Elisa

AU - Vercellati, Cristina

AU - Marcello, Anna Paola

AU - Zaninoni, Anna

AU - Aytac, Selin

AU - Cetin, Mualla

AU - Capolsini, Ilaria

AU - Casale, Maddalena

AU - Paci, Sabrina

AU - Zanella, Alberto

AU - Barcellini, Wilma

AU - Bianchi, Paola

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Glucose-6-phosphate isomerase (GPI, EC 5.3.1.9) is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate, the second reaction step of glycolysis. GPI deficiency, transmitted as an autosomal recessive trait, is considered the second most common erythro-enzymopathy of anaerobic glycolysis, after pyruvate kinase deficiency. Despite this, this defect may sometimes be misdiagnosed and only about 60 cases of GPI deficiency have been reported. GPI deficient patients are affected by chronic nonspherocytic hemolytic anemia of variable severity; in rare cases, intellectual disability or neuromuscular symptoms have also been reported. The gene locus encoding GPI is located on chromosome 19q13.1 and contains 18 exons. So far, about 40 causative mutations have been identified. We report the clinical, hematological and molecular characteristics of 12 GPI deficient cases (eight males, four females) from 11 families, with a median age at admission of 13 years (ranging from 1 to 51); eight of them were of Italian origin. Patients displayed moderate to severe anemia, that improves with aging. Splenectomy does not always result in the amelioration of anemia but may be considered in transfusion-dependent patients to reduce transfusion intervals. None of the patients described here displayed neurological impairment attributable to the enzyme defect. We identified 13 different mutations in the GPI gene, six of them have never been described before; the new mutations affect highly conserved residues and were not detected in 1000 Genomes and HGMD databases and were considered pathogenic by several mutation algorithms. This is the largest series of GPI deficient patients so far reported in a single study. The study confirms the great heterogeneity of the molecular defect and provides new insights on clinical and molecular aspects of this disease.

AB - Glucose-6-phosphate isomerase (GPI, EC 5.3.1.9) is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate, the second reaction step of glycolysis. GPI deficiency, transmitted as an autosomal recessive trait, is considered the second most common erythro-enzymopathy of anaerobic glycolysis, after pyruvate kinase deficiency. Despite this, this defect may sometimes be misdiagnosed and only about 60 cases of GPI deficiency have been reported. GPI deficient patients are affected by chronic nonspherocytic hemolytic anemia of variable severity; in rare cases, intellectual disability or neuromuscular symptoms have also been reported. The gene locus encoding GPI is located on chromosome 19q13.1 and contains 18 exons. So far, about 40 causative mutations have been identified. We report the clinical, hematological and molecular characteristics of 12 GPI deficient cases (eight males, four females) from 11 families, with a median age at admission of 13 years (ranging from 1 to 51); eight of them were of Italian origin. Patients displayed moderate to severe anemia, that improves with aging. Splenectomy does not always result in the amelioration of anemia but may be considered in transfusion-dependent patients to reduce transfusion intervals. None of the patients described here displayed neurological impairment attributable to the enzyme defect. We identified 13 different mutations in the GPI gene, six of them have never been described before; the new mutations affect highly conserved residues and were not detected in 1000 Genomes and HGMD databases and were considered pathogenic by several mutation algorithms. This is the largest series of GPI deficient patients so far reported in a single study. The study confirms the great heterogeneity of the molecular defect and provides new insights on clinical and molecular aspects of this disease.

KW - Chronic hemolytic anemias

KW - Glucose-6-phosphate isomerase deficiency

KW - Glycolysis

KW - Red cell disorders

KW - Red cell metabolism

UR - http://www.scopus.com/inward/record.url?scp=85068216750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068216750&partnerID=8YFLogxK

U2 - 10.3389/fphys.2019.00467

DO - 10.3389/fphys.2019.00467

M3 - Article

AN - SCOPUS:85068216750

VL - 10

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

IS - MAY

M1 - 467

ER -